AAAAAA

   
Results: 1-13 |
Results: 13
EFFICACY OF STANDARD CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH POOR-RISK NON-HODGKINS-LYMPHOMA (NHL)
Authors: DOORDUIJN JK VANDERHOLT B BREED WPM VANDERHEM KG VANIMHOFF GW KRAMER MHH KOOY MV VANOERS MHJ OSSENKOPPELE GJ RICHEL DJ ROOZENDAAL KJ VANTVEER MB VERDONCK LF VERHOEF G WIJERMANS PW SONNEVELD P
Citation: Jk. Doorduijn et al., EFFICACY OF STANDARD CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH POOR-RISK NON-HODGKINS-LYMPHOMA (NHL), British Journal of Haematology, 102(1), 1998, pp. 149-149
EFFECTS OF BRYOSTATIN-1 ON CHRONIC MYELOID-LEUKEMIA DERIVED HEMATOPOIETIC PROGENITORS
Authors: THIJSEN SFT SCHUURHUIS GJ VANDERHEM KG VANOOSTVEEN JW THEIJSMEIJER AP ODDING JH OSSENKOPPELE GJ
Citation: Sft. Thijsen et al., EFFECTS OF BRYOSTATIN-1 ON CHRONIC MYELOID-LEUKEMIA DERIVED HEMATOPOIETIC PROGENITORS, Experimental hematology, 25(8), 1997, pp. 461-461
HIGH-DOSE MELPHALAN WITH RE-INFUSION OF UNPROCESSED, G-CSF-PRIMED WHOLE-BLOOD IS EFFECTIVE AND NONTOXIC THERAPY IN MULTIPLE-MYELOMA
Authors: OSSENKOPPELE GJ SCHUURHUIS GJ JONKHOFF AR VANDERHEM KG LEGDEUR MCJC BOOTBAKKER A WESTRA AH DRAGER AM HUIJGENS PC
Citation: Gj. Ossenkoppele et al., HIGH-DOSE MELPHALAN WITH RE-INFUSION OF UNPROCESSED, G-CSF-PRIMED WHOLE-BLOOD IS EFFECTIVE AND NONTOXIC THERAPY IN MULTIPLE-MYELOMA, European journal of cancer, 32A(12), 1996, pp. 2058-2063
HETEROGENOUS EFFECTS OF BRYOSTATIN ON HUMAN MYELOID-LEUKEMIA CLONOGENICITY - DOSE AND TIME SCHEDULING DEPENDENCY
Authors: VANDERHEM KG SCHUURHUIS GJ DRAGER AM ODDING JH HUIJGENS PC
Citation: Kg. Vanderhem et al., HETEROGENOUS EFFECTS OF BRYOSTATIN ON HUMAN MYELOID-LEUKEMIA CLONOGENICITY - DOSE AND TIME SCHEDULING DEPENDENCY, Leukemia research, 20(9), 1996, pp. 743-750
EFFECTS OF BRYOSTATIN-5 AND HEMATOPOIETIC GROWTH-FACTORS ON ACUTE MYELOID-LEUKEMIA CELL-DIFFERENTIATION, PROLIFERATION, AND PRIMARY PLATINGEFFICIENCY
Authors: VANDERHEM KG DRAGER AM ODDING JH HUIJGENS PC
Citation: Kg. Vanderhem et al., EFFECTS OF BRYOSTATIN-5 AND HEMATOPOIETIC GROWTH-FACTORS ON ACUTE MYELOID-LEUKEMIA CELL-DIFFERENTIATION, PROLIFERATION, AND PRIMARY PLATINGEFFICIENCY, Leukemia research, 19(9), 1995, pp. 651-657
BRYOSTATIN-5 STIMULATES NORMAL HUMAN HEMATOPOIESIS AND INHIBITS PROLIFERATION OF HL-60 LEUKEMIC-CELLS
Authors: VANDERHEM KG DRAGER AM ODDING JH LANGENHUIJSEN MMAC HUIJGENS PC
Citation: Kg. Vanderhem et al., BRYOSTATIN-5 STIMULATES NORMAL HUMAN HEMATOPOIESIS AND INHIBITS PROLIFERATION OF HL-60 LEUKEMIC-CELLS, Leukemia research, 19(1), 1995, pp. 7-13
THE DIFFERENTIATION-INDUCING EFFECT OF BRYOSTATIN-5 ON HUMAN MYELOID BLAST CELLS IS POTENTIATED BY VITAMIN-D-3
Authors: VANDERHEM KG DRAGER AM HUIJGENS PC TOL C DEVILLE W LANGENHUIJSEN MMAC
Citation: Kg. Vanderhem et al., THE DIFFERENTIATION-INDUCING EFFECT OF BRYOSTATIN-5 ON HUMAN MYELOID BLAST CELLS IS POTENTIATED BY VITAMIN-D-3, Leukemia, 8(2), 1994, pp. 266-273
PERIPHERAL-BLOOD PROGENITORS MOBILIZED BY G-CSF (FILGRASTIM) AND REINFUSED AS UNPROCESSED AUTOLOGOUS WHOLE-BLOOD SHORTEN THE PANCYTOPENIC PERIOD FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA
Authors: OSSENKOPPELE GJ JONKHOFF AR HUIJGENS PC NAUTA JJP VANDERHEM KG DRAGER AM LANGENHUIJSEN MMAC
Citation: Gj. Ossenkoppele et al., PERIPHERAL-BLOOD PROGENITORS MOBILIZED BY G-CSF (FILGRASTIM) AND REINFUSED AS UNPROCESSED AUTOLOGOUS WHOLE-BLOOD SHORTEN THE PANCYTOPENIC PERIOD FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA, Bone marrow transplantation, 13(1), 1994, pp. 37-41
UNPROCESSED WHOLE-BLOOD OBTAINED AFTER G-CSF PRIMING HASTENS HEMATOLOGIC RECOVERY IN PATIENTS WITH LYMPHOID MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY
Authors: OSSENKOPPELE GJ JONKHOFF AR VANDERHEM KG LEGDEUR MCJC SCHUURHUIS GJ DRAGER AM HUIJGENS PC
Citation: Gj. Ossenkoppele et al., UNPROCESSED WHOLE-BLOOD OBTAINED AFTER G-CSF PRIMING HASTENS HEMATOLOGIC RECOVERY IN PATIENTS WITH LYMPHOID MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000092-10000092
BRYOSTATIN-5 INDUCES LEUKEMIC-CELL DIFFERENTIATION
Authors: VANDERHEM KG DRAGER AM HUIJGENS PC LANGENHUIJSEN MMAC
Citation: Kg. Vanderhem et al., BRYOSTATIN-5 INDUCES LEUKEMIC-CELL DIFFERENTIATION, Experimental hematology, 21(8), 1993, pp. 1046-1046
PERIPHERAL STEM-CELLS MOBILIZED BY G-CSF AND REINFUSED AS UNPROCESSEDAUTOLOGOUS WHOLE-BLOOD HASTEN BONE-MARROW RECOVERY FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA
Authors: OSSENKOPPELE GJ JONKHOFF AR HUIJGENS PC VANDERHEM KG DRAGER AM LANGENHUIJSEN MMAC
Citation: Gj. Ossenkoppele et al., PERIPHERAL STEM-CELLS MOBILIZED BY G-CSF AND REINFUSED AS UNPROCESSEDAUTOLOGOUS WHOLE-BLOOD HASTEN BONE-MARROW RECOVERY FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA, Experimental hematology, 21(8), 1993, pp. 1163-1163
REINFUSION OF UNPROCESSED WHOLE-BLOOD AFTER G-CSF INDUCED STEM-CELL MOBILIZATION SHORTENS THE PANCYTOPENIC PERIOD AFTER HIGH-DOSE MELPHALAN
Authors: OSSENKOPPELE GJ JONKHOFF AR HUIJGENS PC VANDERHEM KG DRAGER AM LANGENHUIJSEN MMAC
Citation: Gj. Ossenkoppele et al., REINFUSION OF UNPROCESSED WHOLE-BLOOD AFTER G-CSF INDUCED STEM-CELL MOBILIZATION SHORTENS THE PANCYTOPENIC PERIOD AFTER HIGH-DOSE MELPHALAN, Blood, 82(10), 1993, pp. 10000264-10000264
EFFECT OF BRYOSTATIN-5 ON NORMAL AND LEUKEMIC CLONOGENIC CAPACITY
Authors: VANDERHEM KG DRAGER AM HUIJGENS PC ODDING JH LANGENHUIJSEN MMAC
Citation: Kg. Vanderhem et al., EFFECT OF BRYOSTATIN-5 ON NORMAL AND LEUKEMIC CLONOGENIC CAPACITY, Blood, 82(10), 1993, pp. 10000493-10000493
Risultati: 1-13 |